Volume 29; Issue supp-S1

Main
Leukemia Research
Volume 29; Issue supp-S1

Leukemia Research

Volume 29; Issue supp-S1

1

Committees

Journal:

Leukemia Research

Year:

2005

File:

PDF, 34 KB

2005

2

O-1 Environmental and molecularepidemiology of myelodysplastic syndromes

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 62 KB

english, 2005

3

O-2 Epidemiology of myelodysplasticsyndromes among Nagasaki atomic bomb survivors

M. Iwanaga, M. Soda, M. Yamamura, S. Atogami, Y. Yoshida, S. Momita, M. Tomonaga

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 62 KB

english, 2005

4

O-4 Role of AML1/RUNX1 in the molecularpathogenesis of MDS

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

5

O-7 Difference in clinical featuresbetween Japanese and German patients with refractory anemia according to the French-American-British classification

A. Matsuda, U. Germing, I. Jinnai, M. Misumi, A. Kuendgen, S. Knipp, M. Iwanaga, Y. Miyazaki, H. Tsushima, M. Bessho, M. Tomonaga

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 152 KB

english, 2005

6

O-9 Familial myelodysplastic syndromein 4 patients with normal karyotype

A. Kuendgen, A. Schonherr, B. Hildebrandt, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

7

O-10 Bmi-1 expression predicts the progression of leukemic stem cells and prognosis in myelodysplastic syndrome

K. Mihara, N. Nakaju, S. Hidani, M. Chowdhury, A. Ihara, H. Hyodo, S. Yasunaga, Y. Takihara, A. Kimura

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 154 KB

english, 2005

8

O-11 Ex vivo expansion of humanhematopoietic stem cells

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

9

O-15 CD45-negative clonal cellswith very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromes

K. Ogata, C. Satoh, M. Tachibana, H. Hyodo, H. Tamura, K. Dan, T. Kimura, Y. Sonoda, T. Tsuji

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

10

O-16 Different CLIP (class II-associated invariant chain peptide) expression on CD7+ and CD7- hematopoietic precursor cell subpopulations in low-risk MDS

A.A. van de Loosdrecht, M.E.D. Chamuleau, L. van Dreunen, G.J. Ossenkoppele

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

11

O-17 Thalidomide analogue CC5013 (revlimid) selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5Q deletion

M. Jadersten, A.-M. Forsblom, E.K. Emanuelsson, M. Merup, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

12

O-20 Noninvasive detection ofmyelodysplastic syndromes using serum proteome profiling

M. Aivado, D. Spentzos, U. Germing, F. Grall, A.A.N. Giagounidis, H.H. Otu, N. Gattermann, R. Haas, C.S. Mitsiades, E.T. Fungi, T.A. Libermann

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

13

O-21 Gene expression profiling of thebone marrow mononuclear cells from patients with myelodysplastic syndrome

Z. Chen, J. Qian, W. Wang, J. Cen, Y. Xue

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 162 KB

english, 2005

14

O-22 Incidence of cytogenetic response in MDS/AML patients with complex karyotype receiving low-dose 5-aza-2′deoxycytidine (decitabine) treatment

M. Lubbert, P.W Wijermans, R. Kunzmann, C. Robbel

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

15

O-23 Cytogenetic and clinical features of unbalanced translocation der(1;7)(g10;p10) in myelodysplastic syndromes

M. Sanada, L. Wang, A. Hangaishi, S. Chiba, H. Mizoguchi, K. Sawada, K. Oyashiki, K. Ozawa, M. Omine, S. Ogawa

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

16

O-24 Global hyper di-methylation ofhistone H3 lysine 9 in neutrophils of myelodysplastic syndrome patients with −7/complex chromosomal abnormalities

M. Ishikawa, F. Yagasaki, D. Okamura, T. Maeda, M. Misumi, Y. Sato, N. Wakimoto, N. Takahashi, A. Matsuda, I. Jinnai, M. Bessho

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

17

O-25 Reversing gene silencing in myelodysplastic syndromes

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

18

O-27 Telomere dysfunction in myelodysplastic syndromes

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

19

O-28 DNA microarray analysis ofmyelodysplastic syndromes with purified CD133-positive stem cell fractions

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

20

O-32 Aberrant expression of YB-1 gene in erythroid cells in myelodysplastic syndrome

H. Harigae, H. Yokoyama, S. Takahashi, T. Fujiwara, K. Ishizawa, J. Kameoka, M. Kaku, T. Sasaki

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 159 KB

english, 2005

21

O-34 Immunosuppressive therapy withATG in low-risk patients with myelodysplastic syndrome

J.J. Molldrem, O. Akande, E. Estey, R. Rios

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 169 KB

english, 2005

22

O-36 Diagnosis of immune pathophysiology in patients with myelodysplastic syndrome

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

23

O-37 Treatment of patients withmyelodysplastic syndrome with cyclosporin A

S. Chen, B. Jiang, W. Da, M. Gong, M. Guan

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

24

O-38 Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013; revlimid) in transfusion dependent (TD) MDS with chromosome 5Q31.1 deletion: Results of the multicenter MDS-003 study

A.F. List, G.W. Dewald, J.M. Bennett, A.A.N. Giagounidis, A. Raza, E.J. Feldman, B.L. Powell, P.L. Greenberg, J.B. Zeldis, R.D. Knight

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

25

O-42 Diagnostic pitfalls in childhoodMDS and JMML

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 148 KB

english, 2005

26

O-45 Treatment for patients relapsingwith juvenile myelomonocytic leukemia after allogeneic stem cell transplantation: The EWOG-MDS study

A. Yoshimi, F. Locatelli, M. Trebo, J. Stary, M. Zecca, D. Wojcik, H. Hasle, E. Bergstrasser, M.M. van den Heuvel-Eibri, C.M. Niemeyer

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 71 KB

english, 2005

27

O-46 Heterogeneity of clinical featuresand outcomes of patients with abnormal cytogenetic clones evolving from aplastic anemia

A. Ohara, S. Ohga, R. Kobayashi, Y. Kosaka, H. Mugishima, M. Tsuchida, F. Bessho, H. Yabe, T. Nakahata, I. Tsukimoto, S. Kojima

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 71 KB

english, 2005

28

O-48 Treatment and biology of iron overload in myelodysplastic syndromes: New oral iron chelating agents

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

29

O-50 New non-invasive methods formonitoring iron overload: Clinical use in MDS — MRI, squid vs. ferritin assessment

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

30

O-51 Chelation therapy inmyelodysplastic syndrome: Update from recent clinical trials with oral agents

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

31

O-53 New therapies in myelodysplasticsyndrome

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

32

O-54 Epigenetic therapy for MDS

P.W. Wijermans, M. Lubbert

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

33

O-55 Arsenic trioxide: A novel approachto the treatment of MDS

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

34

O-56 Hematopoietic stem cell strategiesin patients with myelodysplastic syndrome and secondary acute myeloid leukemia: The role of reduced intensity conditioning regimens

T.M. De Witte, M. Oosterveld

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

35

O-57 Hemopoietic cell transplantationfor the treatment of MDS

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

36

O-58 Outcomes after umbilical-cord blood transplantation from unrelated donors (UCBT) in patients with myelodysplastic syndromes (MDS). A Eurocord study

G.F. Sanz, V. Rocha, S. Asano, M. de Lima, I. Ionescu, E. Gluckman

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

37

O-59 Allogeneic stem celltransplantation for patients with myelodysplastic syndrome (MDS). Results of the Japan society for hematopoietic cell transplantation (JSHCT)

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 72 KB

english, 2005

38

O-60 WT1 (Wilms' tumor gene) peptide-based immunotherapy for myelodysplastic syndrome

H. Sugiyama, A. Tsuboi, M. Kawakami, Y. Oji, Y. Oka

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 72 KB

english, 2005

39

O-61 Molecular analysis of CTL responses in myelodysplastic syndrome and other bone marrow failure states

M.W. Wlodarski, L. Gondek, Z. Nearman, C. O'Keefe, A. Rodriguez, J.P. Maciejewski

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 147 KB

english, 2005

40

O-62 Monocyte-derived dendriticcells from mds patients are able to induce T-lymphocytes proliferation, but not cell-mediated cytotoxicity — where is the problem?

R. Neuwirtova, V. Cukrova, R. Spisek, R. Pytlik

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

41

O-66 Role of high-intensity therapyfollowed by G-CSF for patients with advanced myelodysplastic syndrome

S. Yano, N. Usui, O. Asai, N. Dobashi, T. Ichiba, H. Osawa, Y. Takei, S. Takahara, Y. Yamaguchi, T. Saito, M. Kobayashi

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

42

O-67 Comparison of “high” and“low” intensity approaches for high-risk MDS

E. Estey, M. Beran, G. Garcia-Manero, H. Kantarjian

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

43

O-68 The role of chemotherapy in the treatment of myelodysplastic syndromes

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

44

O-69 Characteristics of therapy-relatedMDS in 133 patients

S. Knipp, A. Kundgen, B. Hildebrandt, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

45

O-70 Vitamin K2 therapy in low-riskmyelodysplastic syndrome: A prospective Japanese study

K. Miyazawa, K. Ohyashiki, N. Akiyama, Y. Kanda, K. Tohyama, M. Omine, K. Mitani, H. Hirai

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 55 KB

english, 2005

46

O-71 High response rate to darbopoetin alpha and sustained response in low risk MDS

L. Mannone, M.C. Quarre, J.F. Bernard, M.O. Beyne-Rauzy, D. Vassilieff, S. Park, S. Cheze, P. Agape, S. Vaultier, F. Dreyfus, P. Fenaux

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 55 KB

english, 2005

47

P-1 Relationship between GSTT1, GSTM1and NQ01 genes polymorphisms and myelodysplastic symdromes

Z. Xiao, L. Yang, X. Zou, Y. Zhang, M. Zhang, Y. Hao

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 71 KB

english, 2005

48

P-2 Prognostic value of bone marrowblast cells and karyotype in myelodysplastic syndrome

S.V. Gritsaev, I.S. Martinkevitch, S.A. Tyranova, M.P. Bakaia, K.M. Abdulkadirov

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 71 KB

english, 2005

49

P-3 Transfusion dependency:Independent prognostic factor for patients with myelodysplastic syndrome

L. Wong, S. Dobin, D. Ladd, W. Koss, T. Wajima

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 150 KB

english, 2005

50

P-4 Prognostic impact of bone marrow cellularity in myelodysplastic syndromes on overall survival

S. Knipp, P. Reinecke, S. Braunstein, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

51

P-5 Presence of peripheral blasts in RAand RARS predicts an unfavourable outcome

S. Knipp, C. Aul, A.A.N. Giagounidis, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

52

P-6 Characteristics of myelodysplastic syndromes in patients under 50 years of age

A. Kuendgen, C. Strupp, M. Aivado, B. Hildebrandt, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

53

P-7 Prognostic factors in refractory anemia according to the French-American-British classification

A. Matsuda, U. Germing, I. Jinnai, M. Misumi, A. Kuendgen, S. Knipp, M. Iwanaga, Y. Miyazaki, H. Tsushima, M. Bessho, M. Tomonaga

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

54

P-8 Influence of smoking on prognosisand cytogenetics in myelodysplastic syndromes

A. Linnemeier, S. Knipp, E. Borsch-Galetke, B. Hildebrandt, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

55

P-9 Evaluation of dynamic prognostic factors in myelodysplastic syndromes — A single-center analysis

T.M. Nosslinger, R. Reisner, H. Tuchler, E. Pittermann-Hooker, M. Pfeilstocker

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 157 KB

english, 2005

56

P-10 Influence of age and gender on survival in MDS: Importance of an IPSS*gender interaction — A multicenter analysis on 1159 patients

M. Pfeilstocker, M.T. Nosslinger, H. Tuchler, C. Strupp, P. Valent, D. Haase, M. Lubbert, A.A.N. Giagounidis, O. Krieger, C. Aul, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

57

P-11 Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS). A study of the Greek MDS study group

A.G. Galanopoulos, A. Symeonidis, H.A. Papadaki, P. Tsaftaridis, A. Aktipi, P. Roussou, M. Protopappa, M. Pappaioannou, N.I. Anagnostopoulos, N. Zoumbos, N.A. Viniou

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

58

P-12 Marrow progenitors in myelodysplastic syndrome (MDS) demonstrate an aberrant cell cycle and DNA damage

D.R. Head, J.W. Jacobberger, M. Jagasia, S. Goodman, L. Flye, S. McClintock-Treep, F. Boulos, F. Jiang, G. Stelzer, R. Briggs, K. Shults

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

59

P-13 Expression of B7 family molecules on blasts of patients with myelodysplastic syndromes (MDS) and de novo acute myeloid leukemia (AML)

H. Tamura, K. Dan, C. Sato, A. Kondo, T. Yamashita, T. Tsuji, K. Nakamura, Y. Shioi, H. Dong, L. Chen, K. Ogata

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

60

P-14 Demographic and disease-related prognostic factors in myelodysplastic syndromes classified according to who criteria

L. Malcovati, M.G. Della Portal, C. Pascutto, M. Maffioli, E. Travaglino, P. Bernasconi, R. Invernizzi, M. Lazzarino, M. Cazzola

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 158 KB

english, 2005

61

P-15 Chronic myelomonocytic leukemia:IPSS best discriminates patients with worse prognosis, in both the dysplastic and the proliferative subtype

A.S. Symeonidis, V. Lambropoulou, E. Michalis, A. Chatzivassilis, A. Kouraklis, A. Galanopoulos, P. Matsouka, N. Anagnostopoulos, P. Iliakis, N. Zoumbos

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

62

P-16 Determination of the response toanemia index (RAI) in patients with MDS. Recognition of this parameter as a major predictor of in vivo response to treatment with rh-EPO

A.S. Symeonidis, M. Leotsinidis, A. Kouraklis, N. Zoumbos

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

63

P-17 Prevalence of HTLV-I carriers among patients with MDS RAEB and AML

K. Matsushita, H. Inoue, A. Ozaki, H. Fujiwara, H. Kawada, M. Yoshimitsu, K. Arimura, T. Kukita, T. Matsumoto, N. Arima

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 154 KB

english, 2005

64

P-18 A new prognostic score foroutcome of patients with high-risk myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (SAML) after intensive antileukemic treatment

M. Oosterveld, S. Suciu, J.P. Marie, A. Ferrant, P. Muus, M. Delforge, E. Hellstrom-Lindberg, S. Amadori, F. Beeldens, R. Willemze, T.M. De Witte

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

65

P-19 French registry of GFM group

F. Dreyfus, J. Feuillard, M.J. Grange, N. Casadevall, M. Tulliez, M. Imbert, L. Roy, F. Isnard, O. Beyne-Rauzy, E. Duchayne, B. Slama, S. Cheze, H. Dombret, C. Hababou, S. Vaultier, M. Guesnu, F. Pica

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

66

P-20 Application of who classification in Chinese patients with primary myelodysplastic syndromes

Z. Xiao, M. Yu, S. Liu, Y. Shao, Y. Hao

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 154 KB

english, 2005

67

P-21 Subgroups of mixedmyelodysplastic and myeloproliferative syndromes (MDS/MPS)

R. Neuwirtova, M. Fricova, J. Voglova, K. Michalova

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

68

P-22 Evaluation of the WHO proposals for the diagnosis of CMML

S. Knipp, A. Kuendgen, B. Hildebrandt, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

69

P-23 Immunohistochemistry of P53 and HBF and chromosome analysis are useful for differentiating MDS(RA) from aplastic anemia

C. Sugisaki, H. Asano, T. Kinoshita, T. Naoe, H. Ohashi, M. Ito, T. Murate

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

70

P-24 Usefullness of PET (PositronEmission Tomography) in the discrimination between hypoplastic myelodysplastic syndromes and aplastic anemia

M. Takatoku, T. Sato, T. Nagai, K. Ozawa

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

71

P-25 Distinct clinical and laboratoryfeatures of RCMD compared to RA may reflect a multistep pathogenesis of MDS. An analysis of 106 patients with early MDS

J. Cermak, K. Michalova, M. Belickova, H. Bruchova, Z. Sieglova, S. Zilovcova, J. Polak, C. Haskovec

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

72

P-26 Structural parameters provided by blood analysis with Sysmex XE 2100N analyzer are helpful for the diagnosis of MDS

G. Leroux, M. Mahmoud, R. Porcher, J.-P. Perol, J.F. Collon, M. Gonthier, V. Eclache, R. Letestu, P. Fenaux, F. Cymbalista

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

73

P-27 Quantitative and easy evaluationof apoptosis using Annexin-V by flow cytometry in myelodysplastic syndrome

I. Masamoto, K. Arimura, K. Matsushita, T. Kuroki, K. Uozumi, N. Arima

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

74

P-28 Refractory anemia with excess of blasts (RAEB): Analysis of reclassification of the WHO

S. Knipp, C. Strupp, A. Kuendgen, M. Aivado, A.A.N. Giagounidis, B. Hildebrandt, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 157 KB

english, 2005

75

P-29 RA and RARS with thrombocytosis:Mixed myelodysplastic/myeloproliferative disorder?

S. Knipp, C. Strupp, A. Bernhardt, E. Misgeld, B. Hildebrandt, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

76

P-30 Prospective validation of the WHO classification of primary myelodysplastic syndromes

A. Kuendgen, S. Knipp, M. Aivado, M. Lara, S. Isa, A. Giagounides, C. Aul, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

77

P-31 3q Cytogenetic aberrations in a series of 223 myelodysplastic syndrome (MDS)/chronic myelomonocytic leukemia (CMML) patients from a single institution

F. Cobol, I. Madrigal, M. Rozman, D. Costa, A. Carrio, E. Arellano, S. Valera, J.L. Aguilar, E. Montserrat, E. Campo, B. Nomdedeu

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 159 KB

english, 2005

78

P-32 Reclassification of FAB chronic myelomonocytic leukemia (CMML) according to the World Health Organization (WHO) criteria: An analysis of 41 patients from a single institution

F. Cobol, E. Sierra, M. Rozman, E. Arellano, A. Carrio, D. Costa, S. Valera, L. Quinto, E. Campo, E. Montserrat, B. Nomdedeu

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

79

P-33 Difference in morphological features between Japanese and German patients with refractory anemia according to the French-American-British classification

M. Misumi, A. Matsuda, U. Germing, I. Jinnai, A. Kuendgen, S. Knipp, M. Aivado, M. Iwanaga, H. Tsushima, M. Bessho, M. Tomonaga

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

80

P-34 Different modalities of bonemarrow blast quantification can influence diagnostic and prognostic evaluation of myelodysplastic syndromes (MDS)

F. Salvi, L. Godio, E. Campa, M.M. Ciriello, D. Ferrero, A. Gallamini, F. Marmont, C. Paparo, A. Stacchini, G. Saglio, A. Levis

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

81

P-35 Incorporation of B2M into riskassessment of patients with MDS improves the discriminatory power of the IPSS: Validation in an independent population of patients

S. Gatto, G. Mengozzi, S. D'Ardia, G. Cametti, F. Ficara, R. Soave, D. Gioia, A. Baraldi, M. Pini, F. Salvi, A. Levis

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

82

P-36 Trisomy 8 alone in myelodysplasticsyndromes: Recognition of the common clinico-hematologic features from 109 patients

A.S. Symeonidis, T. Marinakis, H. Papadakis, A. Kouraklis, A. Galanopoulos, P. Roussou, E. Terpos, N.A. Viniou, S. Polyclronopoulou, C. Tsatalas, N. Zoumbos

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 157 KB

english, 2005

83

P-37 Flow cytometric analysis of cytosolic and mitochondrial ferritins in immature red blood cells from patients with myelodysplastic syndrome

M.G. Della Porta, L. Malcovati, M. Maffioli, E. Travaglino, S. Levi, P. Arosio, R. Invernizzi, M. Cazzola

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

84

P-38 Subacute myeloid leukemia inmyelodysplastic syndromes

J.-y. Qiu, Y. Zhang, D.-p. Lu, Y.-y. Lai, Q. He, Y. Shi

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

85

P-39 Correlation between apoptosis and SDF-1/CXCR4 system in CD34 positive cells in myelodysplastic syndrome

M. Matsuda, Y. Morita, H. Hanamoto, M. Tanaka, Y. Tatsumi, Y. Maeda, A. Kanamaru

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 156 KB

english, 2005

86

P-40 Establishment of cytokine-independent human myelodysplastic cell line and its characterization

B. Chen, Z. Shao, G. Xia, M. Xue, C. Gao, J. Ding, Y. Sun, J. Wang, J. Cheng, F. Fei, X. Gao

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

87

P-41 Aberrant mitochondrial iron distribution and maturation arrest characterizes early erythroid precursors in low-risk myelodysplastic syndromes

R. Tehranchi, R. Invernizzi, A. Grandien, B. Zhivotovsky, B. Fadeel, A.-M. Forsblom, E. Travaglino, J. Samuelsson, M. Cazzola, R. Wibom, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

88

P-42 Immediate early response gene 1 (IEX-1) is decreased in CD34+ bone marrow cells from patients with myelodysplastic syndromes

W.C. Prall, A. Czibere, M. Aivado, F. Grall, A.A.N. Giagounidis, B. Junge, H.H. Otu, T.A. Libermann, N. Gattermann, U. Germing, R. Haas

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

89

P-43 Effect of the treatment withCA2 anti-TNFα monoclonal antibody on the bone marrow (BM) progenitor cell reserve and function and stromal cell function in patients with myelodysplastic syndrome (MDS). A study of the Greek mds study group

H.A. Papadaki, M. Voulgarelis, A. Boula, G. Katrinakis, C. Pontikoglou, E. Stavroulaki, A. Symeonidis, P. Tsaftaridis, N.A. Viniou, G.D. Eliopoulos, A.G. Galanopoulos

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

90

P-44 Longitudinal assessment ofhematopoietic abnormalities following autologous hematopoietic cell transplantation for lymphoma and association with risk of therapy-related myelodysplasia

R. Bhatia, A. Palmer, A. Komiya, M.L. Slovak, K.L. Chang, A. Krishnan, R. Nakamura, M. O'Donnell, R. Rodriguez, S.J. Forman, S. Bhatia

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

91

P-45 NF-κB is a potential therapeutictarget in high risk MDS: Induction of apoptosis by bortezomib and BAY 11-7082

T. Braun, G. Carvalho, M.-C. Vozenin, J.-J. Kiladjian, F. Hirsch, P. Fenaux, G. Kroemer

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

92

P-46 Cultural methods in the searchof the etiology, pathogenesis and classification of MDS

T. Saralidze, M. Sheklashvili, T. Shvelidze, L. Mohchevishvili, K. Saralidze

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 149 KB

english, 2005

93

P-47 Lack of mutations of the humantelomerase RNA gene (HTERC) in myelodysplastic syndromes

K. Ohyashiki, Y. Ishii, S. Honda, G. Sashida, Y. Zhang, J.H. Ohyashiki

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

94

P-48 rap1b point mutations homologousto activating RAS mutations are uncommon during MDS leukemic transformation

E. Gyan, D. Bowen, M. Frew, C. Beldjord, C. Preudhomme, F. Dreyfus, P. Mayeux, C. Lacombe, F. Porteu, M. Fontenay

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

95

P-49 Expression of 7 cases of MDR (multi-drugresistance)1 in MDS cases with progression to overt leukemia

Y. Nakagawa, M. Hasegawa, S. Abe, K. Suzuki, M. Kitagawa

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

96

P-50 Investigation on the cellular origin of fibrous tissue in a case with myelofibrosis

H. Ohashi, T. Tabuchi, N. Susaki, S. Fukami, S. Kunishima, S. Moritani, S. Ichihara, M. Hamaguchi, H. Saito

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

97

P-51 Phosphatidylinositol glycan-class a (PIG-A) gene mutations in patients with aplastic anemia (AA) and myelodysplastic syndrome (MDS)

H. Noji, T. Shichishima, M. Okamoto, K. Ikeda, A. Nakamura, Y. Maruyama

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 154 KB

english, 2005

98

P-52 Study of DNA repair geneexpression in MDS patients with shortened telomeres and multiple chromosomal abnormalities by array-based comparative genomic hybridization (A-CGH)

L. Gondek, C. O'Keefe, M. Wlodarski, J.P. Maciejewski

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

99

P-53 Evaluation of CD4 and CD8 lymphocytes as normal controls for humara clonality assay in MDS

T. Mitsui, A. Yamane, H. Koiso, H. Handa, T. Matsushima, N. Tsukamoto, H. Murakami, Y. Nojima, M. Karasawa

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

100

P-54 Telomere length control bytelomere binding proteins, TRF1, TRF2 and POT1, in myelodysplastic syndrome

S. Honda, J.H. Ohyashiki, T. Takaku, Y. Ishii, G. Sashida, T. Tauchic, K. Ohyashiki

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 145 KB

english, 2005

101

P-55 5 Azacytidine in myelodysplasticsyndromes: Correlation between clinical responses and CDKN2B promoter methylation

K. Rai, A. John, A. Ho, N.S. Thomas, G. Mufti

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

102

P-56 CDKN2B (Pl5INK4B) and CDKN1A(P21CIP1) promoter hypermethylation occurs in lymphocytes and not in CD34+ or CD33+ myeloid cells of MDS patients

A. John, R. Kavita, N.S. Thomas, G. Mufti

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

103

P-57 Autoimmune manifestations inhuman myelodysplasia. A positive correlation with interferon regulatory factor-1 (IRF-1) expression

S. Giannouli, P.D. Ziakas, C.I. Maratheftis, D. Tzoanopoulos, K. Ritis, G. Kartalis, H.M. Moutsopoulos, M. Voulgarelis

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

104

P-58 Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells

C.I. Maratheftis, S. Giannouli, P.D. Ziakas, P.E. Bolaraki, E.K. Kapsogeorgou, H.M. Moutsopoulos, M. Voulgarelis

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

105

P-59 Proteomics approach to identifyingproteins abnormally expressed in neutrophils in patients with myelodysplastic syndrome

H. Kazama, M. Teramural, K. Yoshinaga, T. Kato, T. Motoji, H. Mizoguehi

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 156 KB

english, 2005

106

P-60 Molecular analysis of ltr of feline leukemia virus derived from cats with myelodysplastic syndromes and analysis of disease potential of the virus

M. Hisasue, K. Nishigaki, N. Nagashima, I. Fukuzawa, K. Ura, R. Tsuchiya, T. Yamada, A. Hasegawa, H. Tsujimoto

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 76 KB

english, 2005

107

P-61 Telomere attrition of lymphocytes in myelodysplastic syndrome: Correlation with clinical findings

G. Sashida, J.H. Ohyashiki, Y. Ishii, S. Honda, T.-i. Takaku, T. Tauchi, K. Ohyashiki

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 76 KB

english, 2005

108

P-62 Telomerase activity inmyelodysplastic syndrome

C.C. Fu, Z.X. Chen

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 155 KB

english, 2005

109

P-63 Effects of alternative splicing and nonsense-mediated mRNA decay on the expression of a variant of GM-CSF receptor beta chain in myelodysplastic syndromes

Y. Shikama, T. Shichishima, I. Matsuoka, T. Maruyama

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

110

P-64 Cytogenetics abnormalities in MDS patients with autoimmune phenomena

R. Feitosa Pinheiro, M. de Lourdes Lopes Ferrari Chauffaille

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

111

P-65 Autoimmune and bleeding manifestations in a case of RAEB-1 with trisomy 8

R. Feitosa Pinheiro, M. de Lourdes Lopes Ferrari Chauffaille

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 158 KB

english, 2005

112

P-66 Characteristics ofmyelodysplastic syndromes with der(1;7)(q10;p10): Report of 19 cases from Japan

H.-H. Hsiao, K. Ohyashiki, G. Sashida, Y. Ito, A. Kodama, Y.-C. Liu, S.-F. Lin

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

113

P-67 Hyperdiploidy in MDS and AML is associated with poor prognosis

S. Balleisen, S. Knipp, A. Kuendgen, B. Hildebrandt, N. Gattermann, R. Haas, B. Royer-Pokora, U. Genning

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

114

P-68 Rare chromosomal abnormalitiesin myelodysplastic syndromes

D.S. Kyriakou, A.-V.S. Karathoda, A. Tsezou, G. Karras, K. Karakousis, N. Stathakis

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 157 KB

english, 2005

115

P-69 Chromosome abnormalities in Chinese patients with primary myelodysplastic syndromes

Z. Xiao, S. Liu, X. Liu, Y. Hao

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

116

P-70 Clinical and molecular cytogeneticstudies in eight patients with myeloid diseases characterized by idic(20)(p11)del(20) (q11q13)

T. Li, Y. Xue, Y. Wu, J. Pan

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

117

P-71 Immunosuppressive therapy (IST) of patients with myelodysplastic syndromes (MDS)

S.V. Gritsaev, K.M. Abdulkadirov, S.A. Tiranova, I.S. Martinkevitch, M.P. Bakaia

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 160 KB

english, 2005

118

P-72 A prospective study using cyclosporin a for low-risk myelodysplastic syndrome

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

119

P-73 Marked improvement produced after laparoscopic splenectomy in hypoplastic refractory anemia (case report)

R. Gologa, C. Vasilescu, C. Dobrea, D. Ostroveanu, D. Marin, D. Vasilache

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

120

P-74 Danazol in the treatment of myelodysplastic syndrome's (MDS) cytopenias: A retrospective analysis of a series of 223 patients from a single institution

F. Cobol, J.M. Roncero, E. Arellano, M. Rozman, D. Costa, J.L. Aguilar, A. Carrio, E. Campo, E. Montserrat, B. Nomdedeu

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 72 KB

english, 2005

121

P-75 The use of erythropoietin inmyelodysplastic syndromes (MDS): Impact on fatigue and quality of life

M. Laudon Thomas, H. Kim, K. Miller, J. Rowel, M. Tallman, J. Houston, R. Van der Jagt, P. Greenberg, D. Cella

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 72 KB

english, 2005

122

P-76 Hemoglobin level threshold in myelodysplastic syndrome: Cardiac hypertrophy and quality of life

E.N. Oliva, F. Benedetto, B. Dimitrov, A. D'Angelo, F. Nobile

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 145 KB

english, 2005

123

P-77 Itraconazole capsules versusfluconazole capsules for anti-fungal chemoprophylaxis in patients with myelodysplastic syndromes or acute myeloid leukemia with multilineage dysplasia

Y. Ito, N. Yamaguchi, M. Sumi, G. Sashida, S. Okabe, T. Katagiri, N. Shoji, O. Iwase, A. Gotoh, K. Ohyashiki

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

124

P-78 Epidemiological survey on myelodysplastic syndromes (MDS) in Piedmont, Italy: Preliminary evaluation of transfusional requirements based on Piedmont MDS registry website

F. Salvi, S. Gatto, L. Biale, A. Darbesio, S. Franceschetti, R. Freilone, F. Gallo, M. Girotto, C. Marinone, F. Scassa, G. Saglio

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

125

P-79 Transfusion and iron overload (IO)in MDS: Impact of infusion chelation therapy (ICT) on quality of life (QoL) and adherence

L.N. Abetz, J.F. Baladi, P. Jones

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

126

P-80 Improved predictive factors ofresponse for myelodysplastic syndrome patients treated by the combination of erythropoietin and G-CSF

S. Park, C. Kelaidi, S. Grabar, V. Bardet, D. Vassilieff, F. Picard, M. Guesnu, M.-C. Quarre, P. Fenaux, F. Dreyfus

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

127

P-81 Possible involvement of fractalkine/CX3CR1 system in dyshematopoiesis in MDS using perforin/granzyme-positive MDS-derived cytotoxic T cell line, K2-MDS

Y. Morita, M. Matsuda, H. Hanamoto, T. Shimada, M. Tanaka, Y. Tatsumi, Y. Maeda, A. Kanamaru

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 149 KB

english, 2005

128

P-82 Chemokine expression in human erythroid leukemia cell line, AS-E2: Macrophage inflammatory protein-3α is induced by proinflammatory cytokines

Y. Inoue, H. Tsushima, Y. Imaizumi, R. Yamasaki, Y. Miyazaki, M. Tomonaga

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 72 KB

english, 2005

129

P-83 Expression of MIP-1α protein in 65 patients with myelodysplastic syndrome (MDS). A study of the Greek MDS study group

D. Mavrogianni, P. Tsaftaridis, E. Terpos, A. Kourakli, M. Papaioannou, P. Roussou, J. Meletis, E. Papadaki, N. Zoumbos, G.A. Pangalis, N.A. Viniou

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 72 KB

english, 2005

130

P-84 Darbepoetin alpha efficacy in myelodysplastic syndrome

E.N. Oliva, F. Ronco, M. Danova, B. Rovati, B. Dimitrov, C. Alati, I. Vincelli, F. Nobile

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

131

P-85 Myelodysplastic syndrome with bone marrow hypoplasia is associated with much higher frequency of apoptosis in CD34+ cells

T. Oyake, S. Ito, S. Kowata, T. Sugawara, K. Murai, Y. Ishida

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

132

P-86 Changes of subsets of Th cellsand DC1 in the bone marrow of severe aplastic anemia and myelodysplastic syndrome

G. He, X. Wang, M. Miao, D. Wu, C. Ruan

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 158 KB

english, 2005

133

P-87 The molecular organization of erythrocyte membrane of children suffering initial myelodysplastic syndrome

N.N. Klimkovich, T.I. Kozarezova, E.I. Slobozhanina, G.M. Zubritskaja

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

134

P-88 Methylation status of the P15 and P16 genes in pediatric myelodysplastic syndrome and juvenile myelomonocytic leukemia

D. Hasegawa, A. Manabe, T. Kubota, H. Kawasaki, Y. Ohtsuka, M. Isomura, S. Kojima, K. Tsuji, T. Nakahata

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

135

P-89 An infant with radio-ulnarsynostosis and myelodysplastic syndrome (RCMD) had trisomy 8 and responded to immunosuppressive therapy

M. Yano, A. Watanabe, G. Takada

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

136

P-90 Mutations in N-RAS and PTPN11 inJapanese patients with juvenile myelomonocytic leukemia

T. Yamamoto, N. Yoshida, M. Isomura, H. Yagasaki, K. Kudo, A. Manabe, S. Kojima

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

137

P-91 Is complete or partial monosomy of the chromosome 7 in pediatric patients a separate disease?

M. Ussowicz, D. Wojcik, W. Pietras, K. Pajdosz, J. Peregud-Pogorzelski, I. Malinowska, T. Jackowska, A. Eliasinska, J.M. Stefaniak, A. Chybicka

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 154 KB

english, 2005

138

P-92 JMML and primary immunodeficiency?A coincidence or?

A.N. Bekassy, K. Gronbak, C. Niemeyer, K.M. Shannon, M. Loh, T. Barington, J. Heldrup

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

139

P-93 Leukemic transformaton in fanconi anemia

M. Matsumoto, M. Yabe, H. Inoue, S. Hamanoue, T. Koike, S. Kojima, M. Tsuchida, K. Muroi, S. Kato, H. Yabe

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

140

P-94 Decreased incidence of clonal evolution to myelodysplastic syndrome with monosomy 7 in children with aplastic anemia following reduced duration G-CSF therapy and early indication for BMT from an alternative donor

H. Yagasaki, K. Kudo, K. Kato, K. Matsumoto, K. Horibe, S. Kojima

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 149 KB

english, 2005

141

P-95 Acute myeloid leukemia (AML)-type chemotherapy for newly diagnosed children with myelodysplastic syndrome (MDS): A Japanese childhood MDS study group trial MDS99

Y. Ohtsuka, A. Manabe, J. Okamura, S. Kojima, A. Ohara, M. Tsuchida, K. Ikuta, S. Hibi, K. Kawa, M. Yabe, A. Watanabe, K.U. eda, S. Nakazawa, S. Miyazaki, T. Nakahata

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

142

P-96 Allogeneic haematopoietic celltransplantation in children with MDS — Single center experience

K. Kalwak, D. Wojcik, M. Ussowicz, K. Pajdosz, E. Gorczynska, D. Turkiewicz, M. Slociak, W. Pietras, A. Chybicka

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

143

P-97 Reduced-intensity allogeneichematopoietic stem cell transplantation for myelodysplastic syndrome

R. Nakamura, R. Rodriguez, J. Palmer, A. Stein, K. Chang, M. Slovak, R. Bhatia, M. Kirschbaum, S.J. Forman, M.R. O'Donnell

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

144

P-98 Naive B lymphocytes expansion in bone marrow and peripheral blood after successful unrelated cord blood transplantation for an adult patient with advanced myelodysplastic syndrome

T. Toubai, J. Tanaka, Y. Shono, S. Ota, D. Hirate, Y. Miura, S. Umehara, N. Toyoshima, M. Asaka, M. Imamura

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

145

P-99 The evolution of the strategy for MDS/JMML in Osaka Medical Center for maternal and child health

A. Sawada, M. Inoue, M. Yasui, T. Yoshimoto, T. Nakano, T. Miyamura, M. Koyama, E. Sato, T. Okamura, K. Yagi, K. Kawa

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 150 KB

english, 2005

146

P-100 Allogeneic hematopoietic stem cell transplantation (HSCT) for myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) evolved from aplastic anemia (AA) in childhood

A. Kikuchi, S. Kojima, K. Tabuchi, A. Ohara, A. Manabe, H. Mugishima, M. Tsuchida, T. Nakahata, I. Tsuksmoto

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

147

P-101 Isolation of the CD34+ progenitorcells in myelodysplastic syndromes with various chromosomal abnormalities: Evidence for involvement in the transformed clone

D.S. Kyriakous, A.-V.S. Karathodas, A. Tsezou, G. Karras, K. Karakousis, N. Stathakiss

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

148

P-102 Use of blood stem cellsimproves results of allogeneic transplantation in patients with myelodysplastic syndrome/secondary acute myelogenous leukemia (MDS/SAML) and a poor-risk karyotype

T.J. Nevill, H.J. Sutherland, K.W. Song, S.H. Nantel, D.E. Hogge, D.L. Forrest, J.C. Lavoie, C.L. Toze, M.J. Barnett, J.D. Shepherd, C.A. Smith

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

149

P-103 Allogeneic stem cell transplantation for Fanconi anemia with leukemic transformation

M. Yabe, H. Inoue, M. Matsumoto, S. Hamanoue, T. Koike, S. Kojima, M. Tsuchida, K. Muroi, S. Kato, H. Yabe

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

150

P-104 Allogeneic hematopoietic stem cell transplantation for MDS

K.-y. Liu, X.-j. Huang, L.-p. Xu, H. Chen, D.-h. Liu, W. Han, J.-z. Wang, Y.-h. Chen, Z.-y. Gao, J. Lu, H.-x. Shi, D.-p. Lu

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 158 KB

english, 2005

151

P-105 The value of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with high-risk myelodysplastic syndromes

A. Horikoshi, K. Takei, Y. Nakaaawa, Y. Hosokawa, S. Sawada

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

152

P-106 Pharmacodynamic study of 5-azacytidine

R. Khan, A. Aggerholm, P. Hokland, M. Hassan, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

153

P-107 Treatment of patients with high-risk MDS and sAML with Bendamustin

S. Knipp, A. Kuendgen, C. Strupp, M. Aivado, R. Haas, N. Gattermann, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 154 KB

english, 2005

154

P-108 Re-treatment results insecond remission of MDS with previous response to low-dose 5-aza-2′-deoxycytidine (decitabine)

B. Ruter, P.W. Wijermans, M. Lubbert

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

155

P-109 MAG mobilization of peripheral blood stem cells and autologous peripheral blood stem cell transplantation in 43 patients with hematopoietic malignancies

H.-y. Qiu, D.-p. Wu, A.-n. Sun, W.-r. Chang, X.-w. Tang, Z.-z. Fu, C. Ruan

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

156

P-110 Thalidomide for the treatmentof low risk myelodysplasia: The ThaI-SMD-200 trial

D. Bouscary, S. Park, D. Vassilie, O. Beyne-Rauzy, A. Aouba, M. Gardembas, L. Sanhes, A. Stamatoullas, P. Fenaux, F. Dreyfus

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 149 KB

english, 2005

157

P-111 Preliminary experience of oral arsenic trioxide in the treatment of refractory myeloid leukaemia

W.Y. Au, C.R. Kumana, Y.L. Kwong

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

158

P-112 Results of a phase II trial with valproic acid (VPA) alone or in combination with all-trans-retinoic acid (ATRA) in 71 patients with myelodysplastic syndromes or SAML/MDS

A. Kuendgen, M. Schmid, S. Knipp, B. Hildebrandt, F. Fox, C. Strupp, C. Steidl, R. Haas, U. Germing, H. Dohner, N. Gattermann

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

159

P-113 The efficacy and tolerabilityof ICL670, a once-daily oral iron chelator, in patients with myelodysplastic syndrome (MDS) and iron overload

N. Gattermann, M. Cazzola, P. Greenberg, J. Maertens, D. Soulieres, C. Rosé, C. Ressayre-Djaffer, D. Alberti, B. Rabault

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

160

P-114 Exisulind selectively inducesapoptosis via c-jun kinase activation in sAML/MDS

A. Czibere, W.C. Prall, L.F. Zerbini, F. Grall, E.C. Craigie, S.D. Ulrich, A.A.N. Giagounidis, R. Haas, T.A. Libermann, M. Aivado

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 65 KB

english, 2005

161

P-115 Bisphosphonate zoledronicacid (ZOL) inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia (JMML) cells

Y. Ohtsuka, A. Manabe, H. Kawasaki, S. Watanabe, Y. Zaike, D. Hasegawa, T. Miyazaki, T. Tanizawa, T. Nakahata, K. Tsuji

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

162

P-116 Comparison of DePeCi (dexamethazone, pentoxyfillin, ciprofloxacin) and DePeCi + amifostine withior without G-CSF in myelodysplastic syndromes (MDS) treatment

J. Dwilewicz-Trojaczeki, K. Madry, E. Wiater, A. Mital, A. Szmigielska, M. Calbecka, B. Sokolowska, M. Wojciechowska, A. Sikorska, A. Pawlowska, K. Gawronski

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 75 KB

english, 2005

163

P-117 Orthomolecular vitamin D3in low-risk myelodysplastic syndrome (MDS): Preliminary results

I. Molnar, N. Stark, B. Powell, J. Lovato, G.G. Schwartz

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

164

P-118 Pilot trial of the histone deacetylase inhibitor depsipeptide in patients with acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS)

V.M. Klimek, S. Fircanis, P. Maslak, P.P. Pandolfi, I. Guernah, M. Baum, T. DeBlasio, J. Wright, S. Sognet, S. Nimer

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

165

P-119 Advanced myelodysplastic syndromes (MDS): Patient subset results of a phase III trial comparing decitabine (DAC) vs. supportive care (SC)

H.I. Saba, J.M. Bennett, C.S. Rosenfeld, J.-P. Issa, C. de Castro, J.F. DiPersio, H.M. Kantarjian

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 166 KB

english, 2005

166

P-120 Low dose all-trans-retinoic acid and androgen therapy for patients with myelodysplastic syndrome

M. Guan, S.-C. Chen, R.-S. Li, C.-W. Ge, H.-L. Zhu

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

167

P-121 Lenalidomide (CC-5013; revlimid™)-inducedred blood cell (RBC) transfusion-independence (TI) responses in low-/INT-1-risk patients with myelodysplastic syndromes (MDS): Results of the multicenter mds 002 study

A. Raza, A.F. List, J.M. Bennett, G. Dewald, F. Feldman, J. Reeves, R. Shadduck, J. Zeldis, R. Knight

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

168

Results of an international phase 2study of the oral farnesyl transferase inhibitor (FTI) tipifarnib (ZARNESTRA®) in patients with high-risk myelodysplastic syndrome (MDS)

P. Fenaux, P. De Porre, A. Raza, G. Mufti, C. Aul, U. Germing, H. Kantarjian, R. Kerstens, R. Kurzrock

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 39 KB

english, 2005

169

Author index

Journal:

Leukemia Research

Year:

2005

File:

PDF, 332 KB

2005

170

O-3 Risk factors for myelodysplastic syndrome and leukemia after breast cancer: Results of a French multicenter case-control study

P. Fenaux, M.-C. Le Deley, F. Suzan, B. Cutuli, S. Delaloge, C. Hill

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

171

O-8 Measurement of telomere length inpatients with early MDS may serve as a prognostic factor

Z. Sieglova, J. Cermak, S. Zilovcova, H. Zizkova, J. Brezinova, Z. Zemanova, K. Michalova

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

172

O-12 Priming of transcription factorsand hematopoietic cell fate decision

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 83 KB

english, 2005

173

O-13 Hematopoietic stem cells in normaland preleukemic disease states

C. Eaves, X. Jiang, A. Eavcs

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 167 KB

english, 2005

174

O-14 A reversible two-step model ofMDS/preleukemia: Transgenic mice expressing inducible BCL2 and mutant NRAS

R.A. Padua, N. Omidvar, S. Kogan, T.-H. Phan, R. West, D. Felsher, I. Weissmann, S. Thomas, J. Whittaker, A. Janin, M. Pla, G. Muftis, J.M. Bishop, C. Chomienne

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

175

O-18 MEF regulates the quiescence of primitive hematopoietic progenitor cells and their susceptibility to myelosuppression

S.D. Nimer, J. Nunes, H.D. Lacorazza

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

176

O-19 Diagnostic value of array-based CGH in MDS

J.P. Maciejewski, C. O'Keefe, M.W. Wlodarski, G. Chen, A. Advani, M. Sekeres

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

177

O-26 Studies in MDS

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 82 KB

english, 2005

178

O-29 Genome-wide high-resolution analysis of DNA copy number changes in myelodysplastic syndromes using high-density oligonucleotide SNP genotyping arrays

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 152 KB

english, 2005

179

O-30 Dysplastic definitive hematopoiesis in AML1/Evi-1 knock-in embryos

K. Mitani, K. Maki, T. Yamagata, H. Hirai

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

180

O-31 A mouse model for human MDS:NUP98-HOXD13 transgenic mice develop MDS that evolve to acute leukemia

Y.-W. Lin, C. Slape, Z. Zhang, P.D. Aplan

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 73 KB

english, 2005

181

O-33 Cryogenetic profile in 2124 patientswith MDS — Correlations with morphology, clinical course and prognosis

D. Haase, C. Steidl, M. Pfeilstocker, B. Hildebrandt, A. Kuendgen, M. Lubbert, A.A.N. Giagounidis, O. Krieger, P. Valent, R. Stauder, U. Germing

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 87 KB

english, 2005

182

O-35 Outcome of immunosuppressivetherapy (IST) for myelodysplastic syndromes (MDS): Results of 21 cases from a single institution

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 84 KB

english, 2005

183

O-40 Lenalidomide inhibits proliferation of chromosome 5 mutant hematopoietic tumor cells and interferes with adaptor protein complex assembly and phosphorylation

A. Krithivas Gandhi, P.H. Schafer, S. Naziruddin, A. Parton, D. Verhelle, H. Brady, D.I. Stirling

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 77 KB

english, 2005

184

O-43 Pediatric myelodysplastic syndromes (MDS) other than juvenile myelomonocytic leukemia (JMML)

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

185

O-44 Juvenile myelomonocytic leukemia (JMML): From clinical examination to molecular genetics

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

186

O-47 Palliative care and myelodysplasia: The importance of a “both/and” approach

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 148 KB

english, 2005

187

O-49 Management of the anemia of MDS

E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 160 KB

english, 2005